Attached files

file filename
EX-99.1 - SPHERIX INCORPORATE INVESTOR FACT SHEET - AIkido Pharma Inc.ex99-1.htm
EX-99.2 - PRESS RELEASE DATED MAY 12, 2014 - AIkido Pharma Inc.ex99-2.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 12, 2014
 
SPHERIX INCORPORATED
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
0-5576
 
52-0849320
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
6430 Rockledge Drive, Suite 503 Bethesda, MD
 
20817
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (703) 992-9260
 
 
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 



 
 
ITEM 7.01
REGULATION FD DISCLOSURE
 
On May 15, 2014, Spherix Incorporated (the “Company”) made available an updated Investor Fact Sheet, in the form attached hereto as Exhibit 99.1, which is incorporated herein by reference.
 
The information in this Current Report, including the presentation attached hereto as Exhibit 99.1, is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in the Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
 
ITEM  8.01
OTHER EVENTS.
 
On May 12, 2014, the Company issued the press release attached hereto as Exhibit 99.2.
 
ITEM 9.01 
FINANCIAL STATEMENTS AND EXHIBITS
 
(d)           Exhibits.
 
The exhibits listed in the following Exhibit Index are furnished as part of this Current Report on Form 8-K.

Exhibit No.
Description
   
99.1
Spherix Incorporated Investor Fact Sheet
99.2
Press Release dated May 12, 2014
 
 
 

 
 
SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date:  May 15, 2014
 
 
SPHERIX INCORPORATED
 
     
By: 
/s/  Anthony Hayes
 
 
Name:  Anthony Hayes
 
 
Title:  Chief Executive Officer